| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIO-TECHNE Corp | Director | Common Stock | 3,782 | $210,392 | $55.63 | 30 Oct 2025 | Direct |
| BIO-TECHNE Corp | Director | Stock Option (Right to Buy) | 3,777 | $210,114 | $55.63 | 30 Oct 2025 | Direct |
| BELLICUM PHARMACEUTICALS, INC | Director | Stock Option (right to buy) | 15,000 | $21,600 | $1.44 | 15 Jun 2022 | Direct |
| BELLICUM PHARMACEUTICALS, INC | Director | Common Stock | 110,098 | 03 Jan 2023 | Direct | ||
| BELLICUM PHARMACEUTICALS, INC | Director | Restricted Stock Units | 0 | 04 Jan 2022 | Direct |